Wuzhou Medical (301234.SZ) announced that the company's chairman, Huang Fan, recently received a notice from the China Securities Regulatory Commission Anhui Regulatory Bureau.
Zhitong Finance APP news, Wuzhou Medical (301234.SZ) announced that the company's chairman, Huang Fan, recently received a decision from the Anhui Regulatory Bureau of the China Securities Regulatory Commission (referred to as the 'Anhui Securities Regulatory Bureau') issuing a "Decision on Issuing a Warning Letter to Huang Fan" (No. [2024] 58).
"Warning Letter" specific content: Huang Fan: After investigation, in January 2016, you signed an equity agency agreement with others, and in September 2016, you transferred the above-mentioned equity to the agent and completed the equity change registration. As the chairman of Anhui Hongyu Wuzhou Medical Instruments Co., Ltd., you did not inform the company of the equity agency matters with others from January to September 2016, resulting in the company's failure to disclose the above-mentioned equity agency situation in the prospectus during the application process. The above actions do not comply with the relevant provisions of Article 4 and Article 40 of the "Administrative Measures for the Initial Public Offering and Listing of Stocks" (CSRC Order No. 196). According to Article 55 of the "Administrative Measures for the Initial Public Offering and Listing of Stocks", our bureau has decided to issue a warning letter to you as an administrative supervision measure and record it in the securities and futures market integrity file.
